Managing clinical conditions: Acanthamoeba

Article

Paul Karpecki, OD, FAAO, and Jill Autry, OD, RPh, shared Acanthamoeba management pearls with attendees at the American Optometric Association’s Optometry’s Meeting.

 

Philadelphia-Paul Karpecki, OD, FAAO, and Jill Autry, OD, RPh, shared clinical management pearls with attendees at the American Optometric Association’s Optometry’s Meeting.

This condition is more common in soft common contact lens wearers-75 to 90 percent of cases.

“Acanthamoeba presentation can mimic herpes simplex," says Dr. Karpecki.

“These patients are in a lot of pain, says Dr. Autry. “The corneal nerves are very inflamed.”

“Treatment is essentially pool chemicals we're throwing into the eye,” says Dr. Karpecki.

The hallmark is gelatinous presentation with disproportionate pain.

Pharmaceutical treatment includes:

• Biguanides

• Diamidines

• Antifungals

• Miconoazole, keraconozale

• Aminoglycosides

• Neomycin

“The only thing to prevent scarring is steroids,” says Dr. Karpecki.

Treatment plan includes:

• Epithelial debridement

• Pain management

• Cycloplegic, opiod, and cautious addition of steroidsODT

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
2 experts in this video
2 experts in this video
Dan Ignaszewski, executive director of the Alliance for Eye and Vision Research and the National Alliance for Eye and Vision Research, provides insight into the new campaign and how to get involved.
© 2025 MJH Life Sciences

All rights reserved.